CLINICAL AND PATHOGENETIC FEATURES OF DAMAGE TO THE NERVOUS SYSTEM AT THE INITIAL CLINICAL STAGES OF HIV-INFECTION
DOI:
https://doi.org/10.11603/1681-2727.2022.4.13705Keywords:
clinic, pathogenesis, asymptomatic course, neuroAIDS, HIV, tests, scalesAbstract
The aim of the study – investigating the features of clinical symptoms in HIV-positive people in the early stages of the disease and their pathogenetic justification.
The study used theoretical methods based on the analysis and synthesis of studying the information of the modern world from the PubMed and Scopus databases, clinical observations, as well as deductive-inductive methods.
Conclusions. As a result of the war in Ukraine, the epidemiological control of infectious diseases on the territory of the country was violated. HIV-infection and the absence or atypicality of its clinical symptoms in infected patients deserve special attention, which is based on a detailed understanding of the pathological processes of neuroAIDS. Damage to astrocyte cells disrupts the connection of cells of the structural and functional complex of the brain with other cells and forms the fundamental basis for understanding clinical symptoms. Most often in the form of: neuropsychic, cognitive somatic and neurological disorders. The pathogenic effect of the virus contributes to spasm of cerebral microvessels, is the cause of local hypoxic lesions, microstrokes, and in late cases – lacunar cerebral infarcts. The active involvement of brain cells in the pathogenesis of HIV-infection has been confirmed by many studies. Along with standard diagnostic methods, it is advisable to use psychoneurological and cognitive tests and scales.
A number of shortcomings have been identified that can reduce the reliability of diagnostic studies when establishing a diagnosis.
Understanding the pathogenetic picture will allow choosing «indicators» for the general diagnostic scheme and increasing the probability of establishing the correct diagnosis, adjusting ART and predicting the further development of the disease.
References
State institution “Public Health Center of the Ministry of Health of Ukraine”, 2022: website. Retrieved from: https://phc.org.ua/kontrol-zakhvoryuvan/vilsnid/statistika-z-vilsnidu (Last accessed: 11.10.2022)
Reddy, D. & Berry, N. S. (2022). Improving HIV medication adherence among forced migrants living with HIV: A qualitative study of refugees and asylum seekers in Malaysia. Conflict and Health, 16 (1) DOI:10.1186/s13031-022-00482-w DOI: https://doi.org/10.1186/s13031-022-00482-w
World Health Organization: website. URL: https://www.who.int/ua/news-room/fact-sheets/detail/hiv-aids (Last accessed: 19.09.2022).
Moskaliuk, V. D., Boyko, Y. I., Randiuk, Y. O., Andrushchak, M. O. (2020). Clinical manifestations of HIV-associated lesions of the central nervous system and the effect of antiretroviral therapy on them. Infektsiyni khvoroby – Infectious Diseases, 1 (2), 73-83 [in Ukrainian]. DOI: https://doi.org/10.11603/1681-2727.2020.2.11288
Peluso, M. J., Ferretti, F., Peterson, J., Lee, E., Fuchs, D., Boschini, A., Spudich, S. (2013). Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well-controlled plasma viral load. AIDS (London, England). 26(14). DOI:10.1097/QAD.0b013e328355e6b2 DOI: https://doi.org/10.1097/QAD.0b013e328355e6b2
Canestri, A., Lescure, F. X., Jaureguiberry, S., Moulignier, A., Amiel, C. (2013). Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clinical Infectious Diseases, 50 (5), 773-778. DOI: https://doi.org/10.1086/650538
Chemych, M., Sosnovenko, D., Yanchuk, S. (2021). Neuroimmune changes in the early diagnosis of HIV-infection. Infectious diseases, 3, 68-74. DOI: https://doi.org/10.11603/1681- 2727.2021.3.12497.
Lau, C. Y., Adan, M. A., Maldarelli, F. (2021). Why the HIV reservoir never runs dry: Clonal expansion and the characteristics of HIV-infected cells challenge strategies to cure and control HIV-infection. Viruses, 13 (12). DOI: 10.3390/v13122512 DOI: https://doi.org/10.3390/v13122512
Mutnal, M. B., Hu, S., Little, M. R., & Lokensgard, J. R. (2011). Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ. Journal of Neurovirology, 17, 424-437. DOI: 10.1007/s13365-011-0042-5 DOI: https://doi.org/10.1007/s13365-011-0042-5
Verkhratsky, A., & Nedergaard, M. (2018). Physiology of astroglia. Physiological reviews, 98 (1), 239-389. DOI: 10.1152/physrev.00042.2016 DOI: https://doi.org/10.1152/physrev.00042.2016
Sagar, V., Pilakka-Kanthikeel, S., Martinez, P. C., Atluri, V. S. R., & Nair, M. (2017). Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS. PLoS One, 12 (8), e0181642. DOI: 10.1371/journal.pone.0181642 DOI: https://doi.org/10.1371/journal.pone.0181642
Zenón, F., Cantres-Rosario, Y., Adiga, R., Gonzalez, M., Rodriguez-Franco, E., Langford, D., & Melendez, L. M. (2015). HIV-infected microglia mediate cathepsin B-induced neurotoxicity. Journal of Neurovirology, 21, 544-558. DOI: 10.1007/s13365-015-0358-7 DOI: https://doi.org/10.1007/s13365-015-0358-7
Werkman, I. L., Lentferink, D. H., & Baron, W. (2021). Macroglial diversity: white and grey areas and relevance to remyelination. Cellular and Molecular Life Sciences, 78, 143-171. DOI: 10.1007/s00018-020-03586-9 DOI: https://doi.org/10.1007/s00018-020-03586-9
Theparambil, S. M., Hosford, P. S., Ruminot, I., Kopach, O., Reynolds, J. R., Sandoval, P. Y., ... & Gourine, A. V. (2020). Astrocytes regulate brain extracellular pH via a neuronal activity-dependent bicarbonate shuttle. Nature Communications, 11 (1), 5073. DOI: 10.1038/s41467-020-18756-3 DOI: https://doi.org/10.1038/s41467-020-18756-3
Adane, M., Amha, H., Tafere, Y., & Alem, G. (2022). Poor sleep quality and associated factors among people attending anti-retroviral treatment clinic at Finote selam general hospital, Amhara, Ethiopia. Sleep Medicine: X, 4, 100054. DOI: 10.1016/j.sleepx.2022.100054 DOI: https://doi.org/10.1016/j.sleepx.2022.100054
Gelman, B. B., Lisinicchia, J. G., Morgello, S., Masliah, E., Commins, D., Achim, C. L., ... & Soukup, V. M. (2013). Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. Journal of Acquired Immune Deficiency Syndromes (1999), 62 (5), 487. DOI: 10.1097/QAI.0b013e31827f1bdb DOI: https://doi.org/10.1097/QAI.0b013e31827f1bdb
All-Ukrainian association for neurology and reflexotherapy website URL: https://neurology.in.ua/ (Last accessed: 1.05.2022).
Schlachetzki, J. C., Zhou, Y., & Glass, C. K. (2022). Human microglia phenotypes in the brain associated with HIV infection. Current Opinion in Neurobiology, 77, 102637. DOI: 10.1016/j.conb.2022.102637 DOI: https://doi.org/10.1016/j.conb.2022.102637
Ensoli, B., Moretti, S., Borsetti, A., Maggiorella, M. T., Buttò, S., Picconi, O., ... & Cafaro, A. (2021). New insights into pathogenesis point to HIV-1 Tat as a key vaccine target. Archives of Virology, 166 (11), 2955-2974. DOI: 10.1007/s00705-021-05158-z DOI: https://doi.org/10.1007/s00705-021-05158-z
Tambussi, G., Gori, A., Capiluppi, B., Balotta, C., Papagno, L., Morandini, B., ... & Lazzarin, A. (2000). Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clinical Infectious Diseases, 30 (6), 962-965. DOI: 10.1086/313810 DOI: https://doi.org/10.1086/313810
Chemych, M., Sosnovenko, D., Chemych, O., Berest, O. (2020). Hematological changes of endogenic intoxication, non-specific reactivity and inflammation activity indices in hiv-infected patients. Wiadomosci Lekarskie, 73 (5), 983-987. DOI: https://doi.org/10.36740/ WLek202005127 DOI: https://doi.org/10.36740/WLek202005127
Branton, W. G., Fernandes, J. P., Mohammadzadeh, N., Doan, M. A., Laman, J. D., Gelman, B. B., ... & Power, C. (2023). Microbial molecule ingress promotes neuroinflammation and brain CCR5 expression in persons with HIV-associated neurocognitive disorders. Brain, Behavior, and Immunity, 107, 110-123. DOI: 10.1016/j.bbi.2022.09.019 DOI: https://doi.org/10.1016/j.bbi.2022.09.019
Seo, J. S., Mantas, I., Svenningsson, P., & Greengard, P. (2021). Ependymal cells-CSF flow regulates stress-induced depression. Molecular Psychiatry, 26 (12), 7308-7315. DOI:10.1038/s41380-021-01202-1 DOI: https://doi.org/10.1038/s41380-021-01202-1
Omondi, F. H., Chandrarathna, S., Mujib, S., Brumme, C. J., Jin, S. W., Sudderuddin, H., ... & Brumme, Z. L. (2019). HIV subtype and Nef-mediated immune evasion function correlate with viral reservoir size in early-treated individuals. Journal of Virology, 93 (6), e01832-18. e01832-18. DOI: 10.1128/JVI.01832-18 DOI: https://doi.org/10.1128/JVI.01832-18
Osborne, O., Peyravian, N., Nair, M., Daunert, S., & Toborek, M. (2020). The paradox of HIV blood–brain barrier penetrance and antiretroviral drug delivery deficiencies. Trends in neurosciences, 43 (9), 695-708. DOI: 10.1016/j.tins.2020.06.007 DOI: https://doi.org/10.1016/j.tins.2020.06.007
McRae, M. (2016). HIV and viral protein effects on the blood brain barrier. Tissue Barriers, 4 (1), e1143543. DOI: 10.1080/21688370.2016.1143543 DOI: https://doi.org/10.1080/21688370.2016.1143543
Bogorodskaya, M., Chow, F. C., & Triant, V. A. (2019). Stroke in HIV. Canadian Journal of Cardiology, 35 (3), 280-287. DOI: 10.1016/j.cjca.2018.11.032 DOI: https://doi.org/10.1016/j.cjca.2018.11.032
McDonnell, J., Haddow, L., Daskalopoulou, M., Lampe, F., Speakman, A., Gilson, R., ... & Rodger, A. (2014). Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men. Journal of Acquired Immune Deficiency Syndromes (1999), 67 (2), 120. DOI: 10.1007/s10461-017-1683-z DOI: https://doi.org/10.1097/QAI.0000000000000273
Yang, Z., Huang, X., Liu, X., Hou, J., Wu, W., Song, A., ... & Wu, H. (2019). Psychometric properties and factor structure of the Chinese version of the hospital anxiety and depression scale in people living with HIV. Frontiers in psychiatry, 10, 346. DOI: 10.3389/fpsyt.2019.00346 DOI: https://doi.org/10.3389/fpsyt.2019.00346
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Infectious diseases
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0
